(Reuters) – Regeneron Pharmaceuticals Inc said on Monday it began late-stage clinical trials to assess the effectiveness of its antibody cocktail in preventing and treating COVID-19, sending its shares up nearly 4%. The trial, run jointly with the National …
See Original Article

Elon Musk has taken to selling short satin shorts in a jibe at short sellers, with the Tesla CEO unveiling a limited edition run of branded hotpants on the company’s website and making good on an earlier promise to hit back at the firm’s skeptics. Donald Trump …
See Original Article

Yesterday I wrote about the allegations of slavery and of poor working conditions in a factory in Leicester which supplies the Nasty Gal brand, owned by Boohoo, following an undercover investigation by The Sunday Times. The story centers around workers in …
See Original Article

Blood plasma giant CSL has begun enrolling patients in a phase two study for a potential treatment for people with COVID-19 suffering severe respiratory distress. On Monday evening the company’s Philadelphia, Pennsylvania office confirmed approximately …
See Original Article

Footfall in England hiked almost 36 per cent on Saturday evening, according to new research, as revellers flocked to high streets around the country to enjoy their first pints out after more than three months of lockdown. New data released by Springboard …
See Original Article